DOCSLIB.ORG

Up-Regulation of C-Jun-NH2-Kinase Pathway Contributes to the Induction of Mitochondria-Mediated Apoptosis by A-Tocopheryl Succinate in Human Prostate Cancer Cells

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Up-Regulation of C-Jun-NH2-Kinase Pathway Contributes to the Induction of Mitochondria-Mediated Apoptosis by A-Tocopheryl Succinate in Human Prostate Cancer Cells Molecular Cancer Therapeutics 43 Up-regulation of c-Jun-NH2-kinase pathway contributes to the induction of mitochondria-mediated apoptosis by A-tocopheryl succinate in human prostate cancer cells Ke Zu,1 Lesleyann Hawthorn,2 and Clement Ip1 Introduction Departments of 1Cancer Chemoprevention and 2Cancer Genetics, Vitamin E is a generic term for two distinct, but Roswell Park Cancer Institute, Buffalo, New York structurally related, groups of compounds: tocopherols and tocotrienols. Numerous studies have convincingly shown the growth-inhibitory activities of vitamin E Abstract compounds in a variety of cancer cell lines (1–5). Among Previously, A-tocopheryl succinate (A-TOS) has been the various naturally occurring vitamin E compounds and reported to induce caspase-mediated apoptosis in PC-3 their synthetic derivatives, a-tocopheryl succinate (a-TOS), human prostate cancer cells. Caspase-9 was among a redox-silent analogue of a-tocopherol, is the most several initiator caspases activated by A-TOS, suggest- commonly used form in in vitro studies of cancer research ing a potential contribution of the intrinsic apoptotic (6, 7). The chemotherapeutic effects of a-TOS include pathway in mediating the response to A-TOS. Gene repressed cell proliferation, cell cycle block, reduced expression microarray was carried out as a screen to DNA synthesis, and induction of apoptosis (3, 8–15). identify novel signaling molecules modulated by A-TOS, Of these different mechanisms, the last one has been with a special focus on those known to play a role in studied most extensively. mitochondria-mediated apoptosis. We discovered that It is generally accepted that there are two principal Ask1, GADD45B, and Sek1, three key components of apoptotic cascades: the receptor-mediated extrinsic path- the stress-activated mitogen-activated protein kinase way and the mitochondria-mediated intrinsic pathway. In pathway, are novel targets of A-TOS. Western blot the presence of external stimuli such as inflammatory analysis showed increased levels of phospho-Sek1 and cytokines or withdrawal of growth factors, specific ligands phospho-c-Jun-NH2-kinase (JNK) in addition to total bind to death receptors such as Fas, leading to the assembly Ask1, GADD45B, and Sek1. A-TOS also altered JNK- of a death-inducing signal complex, and the recruitment specific phosphorylation of Bcl-2 and Bim in a manner and activation of initiator caspase-8. Independent of the consistent with enhanced mitochondrial translocation of above mechanism, the mitochondria-mediated pathway is Bax and Bim. Because the expression level of most Bcl-2 activated by internal death stimuli such as reactive oxygen family members remained unchanged, the posttransla- species, culminating in the release of cytochrome c from the tional modification of Bcl-2 and Bim by JNK is likely to mitochondria into the cytoplasm. Following the binding of be a driving force in A-TOS activation of the intrinsic cytochrome c to Apaf-1, procaspase-9 is recruited to the apoptotic pathway. Based on our findings, we propose complex and activated by the cofactor Apaf-1 through the a working model to capture the salient features of the caspase recruitment domain. Once activated, initiator A apoptotic signaling circuitry of -TOS. [Mol Cancer Ther caspase-8 and caspase-9 cleave and activate downstream 2005;4(1):43–50] effector caspase-3, -6, and -7 to complete the escalation of the caspase cascade. The whole process is geared ultimately to the execution of apoptotic cell death (16, 17). The Bcl-2 family proteins are critical regulators of the mitochondrial pathway of apoptosis (16–19). They are believed to modulate the permeability of the mitochondrial membrane directly and thereby control the release of Received 9/9/04; revised 10/29/04; accepted 11/8/04. cytochrome c. Based on the Bcl-2 homology domain Grant support: Supported by grant CA 91990 from the National Cancer Institute, and partially supported by core resources of the Roswell Park structures and protein functions, the Bcl-2 family can be Cancer Institute Cancer Center support grant P30 CA 16056 from the classified into three groups: the antiapoptotic members National Cancer Institute. (containing all four BH domains) such as Bcl-2 and Bcl-xL, The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked the proapoptotic members (containing only BH1, BH2, and advertisement in accordance with 18 U.S.C. Section 1734 solely to BH3 domains) such as Bax and Bak, and the BH3 domain– indicate this fact. only members such as Bad, Bim, and Bid. Apoptotic Requests for reprints: Clement Ip, Department of Cancer Chemoprevention, signaling triggers Bax translocation from the cytosol to Roswell Park Cancer Institute, Elm and Carlton Streets, Buffalo, NY 14263. Phone: 716-845-8875; Fax: 716-845-8100. the outer mitochondrial membrane. In contrast to Bax, Bak E-mail: [email protected] is localized primarily in the outer mitochondrial mem- Copyright C 2005 American Association for Cancer Research. brane. When cued by apoptotic signals, Bax and Bak Mol Cancer Ther 2005;4(1). January 2005 Downloaded from mct.aacrjournals.org on September 27, 2021. © 2005 American Association for Cancer Research. 44 Apoptosis signaling induced by a-tocopheryl succinate oligomerize and form heterotetrameric channels for the exit Quantitation of Apoptosis by Terminal Deoxynucleo- of cytochrome c. Bcl-2 and Bcl-xL, on the other hand, tidyl Transferase-Mediated Nick End Labeling prevent apoptosis by inhibiting the formation of the Bax/ PC-3 cells were plated at a density of 4,000 cells/cm2 Bak heterotetrameric channels. Furthermore, the phosphor- in T175 culture flasks. At 72 hours after seeding, cells ylation of the Bcl-2 protein is involved in the regulation of were exposed to 20 or 40 Amol/L a-TOS for 24 hours. its function. The BH3 domain–only proteins are usually Adherent cells harvested by mild trypsinization were localized in the cytosol and function as death ligands to the pooled together with detached cells. The cell pellets were multidomain Bcl-2 family members. Upon activation by then fixed in 1% (w/v) paraformaldehyde in PBS apoptotic stimuli, the BH3 domain–only proteins translo- (pH 7.4), washed in PBS, and stored in 70% ethanol at cate to the mitochondria; the above process is regulated by 4jC overnight. The ethanol solution was subsequently different mechanisms. For example, Bim is sequestered in removed following centrifugation, and cells were treated the cytosol by binding to the dynein motor complexes. with the enzyme terminal deoxynucleotidyl transferase- Phosphorylation by c-Jun-NH2-kinase (JNK) disrupts the mediated nick end labeling, labeled with bromodeoxyur- binding motif of Bim and facilitates the release of Bim, thus idine, and stained with fluorescein fPRB-1 antibody and making it available to antagonize Bcl-2 in the mitochondria. propidium iodide using the apo-bromodeoxyuridine kit Previously, we found that caspase-9, the key initi- from Phoenix Flow Systems (San Diego, CA) as per the ator caspase of mitochondria-mediated apoptosis, is manufacturer’s protocol. Apoptotic cells were counted by activated in PC-3 human prostate cancer cells treated with flow cytometry, and the data were analyzed with the a-TOS (15). The significance of the mitochondrial pathway WinList software. in a-TOS-induced apoptosis has similarly been impli- Oligonucleotide Array Analysis cated by Kline et al. and Neuzil et al. in different cell PC-3 cells were plated at a density of 4,000 cells/cm2 models (20–22). In the present study, we used gene expres- in 15-cm culture dishes. Synchronization of cells was sion microarray as a first step to identify novel signaling achieved by starving in serum-free medium for 48 hours. molecules modulated by a-TOS, with a special focus on After returning to regular growth medium for 6 hours, those that are known to play a role in mitochondria- cells were exposed to regular growth medium or mediated apoptosis. Based on further research aimed at 20 Amol/L a-TOS for 24 hours. Total RNA and protein validating the discovery, a working model is proposed to were then isolated using TRIzol (Life Technologies, Inc., delineate the molecular mechanism that may underlie the Gaithersburg, MD). The experiment was repeated twice proapoptotic activity of a-TOS. more, and total RNA collected from the three replicates were pooled and submitted to microarray analysis using Materials and Methods the U95A chip from Affymetrix (Santa Clara, CA). Cell Culture Condition Biotinylated cRNA probe generation, array hybridization, The PC-3 human prostate cancer cell line was purchased and other procedures were carried out according to the from American Type Culture Collection (Manassas, VA). standard Affymetrix GeneChip protocol. Fluorescence Cells were cultured in RPMI 1640 medium supplemented intensity for each chip was captured with a Hewlett- with 10% fetal bovine serum, 100 units/mL penicillin, Packard laser confocal scanner. Three data analysis 100 Ag/mL streptomycin, and 2 mmol glutamine, and parameters from the Affymetrix Microarray Suite soft- j maintained in an atmosphere of 5% CO2 in a 37 C ware were used to determine a change in gene humidified incubator. Ethanol was used to dissolve a- expression between the control and treatment samples: TOS (Sigma, St. Louis, MO); the final concentration of detection (a qualitative measure of the presence or ethanol in the culture medium was kept at 0.2% (v/v). absence of a particular transcript), change (a qualitative MTT Cell Growth Assay measure of the increase or decrease of a particular This assay is based on the conversion of the yellow transcript), and signal log ratio (a quantitative measure tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenylte- of the increase or decrease of a particular transcript). A trazolium bromide (MTT) to purple formazan crystals detailed description of the analysis of the microarray data by metabolically active cells.
Load more

Recommended publications
  • Wt1) – an Effector in Leukemogenesis?
    WILMS’ TUMOUR GENE 1 PROTEIN (WT1) – AN EFFECTOR IN LEUKEMOGENESIS? Vidovic, Karina 2010 Link to publication Citation for published version (APA): Vidovic, K. (2010). WILMS’ TUMOUR GENE 1 PROTEIN (WT1) – AN EFFECTOR IN LEUKEMOGENESIS?. Lund University: Faculty of Medicine. Total number of authors: 1 General rights Unless other specific re-use rights are stated the following general rights apply: Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal Read more about Creative commons licenses: https://creativecommons.org/licenses/ Take down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. LUND UNIVERSITY PO Box 117 221 00 Lund +46 46-222 00 00 Download date: 07. Oct. 2021 Division of Hematology and Transfusion Medicine Lund University, Lund, Sweden WILMS’ TUMOUR GENE 1 PROTEIN (WT1) – AN EFFECTOR IN LEUKEMOGENESIS? Karina Vidovic Thesis 2010 Contact adress Karina Vidovic Division of Hematology and Transfusion Medicine BMC, C14 Klinikgatan 28 SE- 221 84 Lund Sweden Phone +46 46 222 07 30 e-mail: [email protected] ISBN 978-91-86443-99-3 ! Karina Vidovic Printed by Media-Tryck, Lund, Sweden 2 ”The journey of a thousand miles begins with one step” Lao Tzu (Chinese taoist), 600-531 BC 3 4 LIST OF PAPERS This thesis is based on the following papers, referred to in the text by their Roman numerals I.
    [Show full text]
  • An Integrated Genome Screen Identifies the Wnt Signaling Pathway As a Major Target of WT1
    An integrated genome screen identifies the Wnt signaling pathway as a major target of WT1 Marianne K.-H. Kima,b, Thomas J. McGarryc, Pilib O´ Broind, Jared M. Flatowb, Aaron A.-J. Goldend, and Jonathan D. Lichta,b,1 aDivision of Hematology/Oncology and cFeinberg Cardiovascular Research Institute, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611; bRobert H. Lurie Cancer Center, Northwestern University, Chicago, IL 60611; and dDepartment of Information Technology, National University of Ireland, Galway, Republic of Ireland Edited by Peter K. Vogt, The Scripps Research Institute, La Jolla, CA, and approved May 18, 2009 (received for review February 12, 2009) WT1, a critical regulator of kidney development, is a tumor suppressor control. A first generation of in vitro cotransfection and DNA for nephroblastoma but in some contexts functions as an oncogene. binding assays have given way to more biologically relevant exper- A limited number of direct transcriptional targets of WT1 have been iments where manipulation of WT1 levels has been accompanied identified to explain its complex roles in tumorigenesis and organo- by examination of candidate or global gene expression. Classes of genesis. In this study we performed genome-wide screening for direct WT1 targets thus identified consist of inducers of differentiation, WT1 targets, using a combination of ChIP–ChIP and expression arrays. regulators of cell growth and modulators of cell death. WT1 target Promoter regions bound by WT1 were highly G-rich and resembled genes include CDKN1A (22), a negative regulator of the cell cycle; the sites for a number of other widely expressed transcription factors AREG (23), a facilitator of kidney differentiation; WNT4 (24), a such as SP1, MAZ, and ZNF219.
    [Show full text]
  • DNA Modifications in Models of Alcohol Use Disorders
    Alcohol 60 (2017) 19e30 Contents lists available at ScienceDirect Alcohol journal homepage: http://www.alcoholjournal.org/ DNA modifications in models of alcohol use disorders * Christopher T. Tulisiak a, R. Adron Harris a, b, Igor Ponomarev a, b, a Waggoner Center for Alcohol and Addiction Research, The University of Texas at Austin, 2500 Speedway, A4800, Austin, TX 78712, USA b The College of Pharmacy, The University of Texas at Austin, 2409 University Avenue, A1900, Austin, TX 78712, USA article info abstract Article history: Chronic alcohol use and abuse result in widespread changes to gene expression, some of which Received 2 September 2016 contribute to the development of alcohol-use disorders (AUD). Gene expression is controlled, in part, by a Received in revised form group of regulatory systems often referred to as epigenetic factors, which includes, among other 3 November 2016 mechanisms, chemical marks made on the histone proteins around which genomic DNA is wound to Accepted 5 November 2016 form chromatin, and on nucleotides of the DNA itself. In particular, alcohol has been shown to perturb the epigenetic machinery, leading to changes in gene expression and cellular functions characteristic of Keywords: AUD and, ultimately, to altered behavior. DNA modifications in particular are seeing increasing research Alcohol fi Epigenetics in the context of alcohol use and abuse. To date, studies of DNA modi cations in AUD have primarily fi fi fi DNA methylation looked at global methylation pro les in human brain and blood, gene-speci c methylation pro les in DNMT animal models, methylation changes associated with prenatal ethanol exposure, and the potential DNA hydroxymethylation therapeutic abilities of DNA methyltransferase inhibitors.
    [Show full text]
  • Gadd45b Acts As Neuroprotective Effector in Global Ischemia- Induced Neuronal Death
    INTERNATIONAL NEUROUROLOGY JOURNAL INTERNATIONAL INJ pISSN 2093-4777 eISSN 2093-6931 Original Article Int Neurourol J 2019;23(Suppl 1):S11-21 NEU INTERNATIONAL RO UROLOGY JOURNAL https://doi.org/10.5213/inj.1938040.020 pISSN 2093-4777 · eISSN 2093-6931 Volume 19 | Number 2 June 2015 Volume pages 131-210 Official Journal of Korean Continence Society / Korean Society of Urological Research / The Korean Children’s Continence and Enuresis Society / The Korean Association of Urogenital Tract Infection and Inflammation einj.org Mobile Web Gadd45b Acts as Neuroprotective Effector in Global Ischemia- Induced Neuronal Death Chang Hoon Cho1,*, Hyae-Ran Byun1,*, Teresa Jover-Mengual1,2, Fabrizio Pontarelli1, Christopher Dejesus1, Ah-Rhang Cho3, R. Suzanne Zukin1, Jee-Yeon Hwang1,4 1Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, New York, NY, USA 2 Unidad Mixta de Investigación Cerebrovascular, Instituto de Investigación Sanitaria La Fe - Universidad de Valencia; Departamento de Fisiología, Universidad de Vale---ncia, Valencia, Spain 3Department of Beauty-Art, Seo-Jeong University, Seoul, Korea 4Department of Pharmacology, Creighton University School of Medicine, Omaha, NE, USA Purpose: Transient global ischemia arising in human due to cardiac arrest causes selective, delayed neuronal death in hippo- campal CA1 and cognitive impairment. Growth arrest and DNA-damage-inducible protein 45 beta (Gadd45b) is a well- known molecule in both DNA damage-related pathogenesis and therapies. Emerging evidence suggests that Gadd45b is an anti-apoptotic factor in nonneuronal cells and is an intrinsic neuroprotective molecule in neurons. However, the mechanism of Gadd45b pathway is not fully examined in neurodegeneration associated with global ischemia.
    [Show full text]
  • Gadd45b Deficiency Promotes Premature Senescence and Skin Aging
    www.impactjournals.com/oncotarget/ Oncotarget, Vol. 7, No. 19 Gadd45b deficiency promotes premature senescence and skin aging Andrew Magimaidas1, Priyanka Madireddi1, Silvia Maifrede1, Kaushiki Mukherjee1, Barbara Hoffman1,2 and Dan A. Liebermann1,2 1 Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, PA, USA 2 Department of Medical Genetics and Molecular Biochemistry, Temple University School of Medicine, Philadelphia, PA, USA Correspondence to: Dan A. Liebermann, email: [email protected] Keywords: Gadd45b, senescence, oxidative stress, DNA damage, cell cycle arrest, Gerotarget Received: March 17, 2016 Accepted: April 12, 2016 Published: April 20, 2016 ABSTRACT The GADD45 family of proteins functions as stress sensors in response to various physiological and environmental stressors. Here we show that primary mouse embryo fibroblasts (MEFs) from Gadd45b null mice proliferate slowly, accumulate increased levels of DNA damage, and senesce prematurely. The impaired proliferation and increased senescence in Gadd45b null MEFs is partially reversed by culturing at physiological oxygen levels, indicating that Gadd45b deficiency leads to decreased ability to cope with oxidative stress. Interestingly, Gadd45b null MEFs arrest at the G2/M phase of cell cycle, in contrast to other senescent MEFs, which arrest at G1. FACS analysis of phospho-histone H3 staining showed that Gadd45b null MEFs are arrested in G2 phase rather than M phase. H2O2 and UV irradiation, known to increase oxidative stress, also triggered increased senescence in Gadd45b null MEFs compared to wild type MEFs. In vivo evidence for increased senescence in Gadd45b null mice includes the observation that embryos from Gadd45b null mice exhibit increased senescence staining compared to wild type embryos.
    [Show full text]
  • Genetic Deletion Ofgadd45b, a Regulator of Active DNA
    The Journal of Neuroscience, November 28, 2012 • 32(48):17059–17066 • 17059 Brief Communications Genetic Deletion of gadd45b, a Regulator of Active DNA Demethylation, Enhances Long-Term Memory and Synaptic Plasticity Faraz A. Sultan,1 Jing Wang,1 Jennifer Tront,2 Dan A. Liebermann,2 and J. David Sweatt1 1Department of Neurobiology and Evelyn F. McKnight Brain Institute, University of Alabama at Birmingham, Birmingham, Alabama 35294 and 2Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, Pennsylvania 19140 Dynamic epigenetic mechanisms including histone and DNA modifications regulate animal behavior and memory. While numerous enzymes regulating these mechanisms have been linked to memory formation, the regulation of active DNA demethylation (i.e., cytosine-5 demethylation) has only recently been investigated. New discoveries aim toward the Growth arrest and DNA damage- inducible 45 (Gadd45) family, particularly Gadd45b, in activity-dependent demethylation in the adult CNS. This study found memory- associated expression of gadd45b in the hippocampus and characterized the behavioral phenotype of gadd45b Ϫ/Ϫ mice. Results indicate normal baseline behaviors and initial learning but enhanced persisting memory in mutants in tasks of motor performance, aversive conditioning and spatial navigation. Furthermore, we showed facilitation of hippocampal long-term potentiation in mutants. These results implicate Gadd45b as a learning-induced gene and a regulator of memory formation and are consistent with its potential role in active DNA demethylation in memory. Introduction along with the finding of activity-induced gadd45b in the hip- Alterations in neuronal gene expression play a necessary role pocampus led us to hypothesize that Gadd45b modulates mem- in memory consolidation (Miyashita et al., 2008).
    [Show full text]
  • Wilms' Tumor Gene 1 in Different Types of Cancer
    UMEÅ UNIVERSITY MEDICAL DISSERTATIONS New Series No.1717 ISSN 0346-6612 ISBN 978-91-7601-263-5 Wilms’ tumor gene 1 in different types of cancer Xingru Li Department of Medical Biosciences, Clinical Chemistry Umeå University, Sweden Umeå 2015 Copyright © 2015 Xingru Li ISBN: 978-91-7601-263-5 ISSN: 0346-6612 Printed by: Print & Media Umeå, Sweden, 2015 To my family Table of Contents Abstract .......................................................................................................... 1 Original Articles ............................................................................................. 2 Abbreviations ................................................................................................. 3 Introduction .................................................................................................... 4 WT1 (Wilms’ tumor gene 1) ...................................................................... 4 Structure of WT1 ..................................................................................... 4 WT1, the transcription factor ................................................................. 5 WT1 and its interacting partners ............................................................ 5 WT1 function .......................................................................................... 8 The tumor suppressor ........................................................................ 8 An oncogene ...................................................................................... 8 Mutations and
    [Show full text]
  • Dysregulation of Meox2 Following Wt1 Mutation in Kidney Development and Wilms Tumorigenesis
    The Texas Medical Center Library DigitalCommons@TMC The University of Texas MD Anderson Cancer Center UTHealth Graduate School of The University of Texas MD Anderson Cancer Biomedical Sciences Dissertations and Theses Center UTHealth Graduate School of (Open Access) Biomedical Sciences 12-2011 DYSREGULATION OF MEOX2 FOLLOWING WT1 MUTATION IN KIDNEY DEVELOPMENT AND WILMS TUMORIGENESIS LaGina M. Nosavanh LaGina Merie Nosavanh Follow this and additional works at: https://digitalcommons.library.tmc.edu/utgsbs_dissertations Part of the Medicine and Health Sciences Commons Recommended Citation Nosavanh, LaGina M. and Nosavanh, LaGina Merie, "DYSREGULATION OF MEOX2 FOLLOWING WT1 MUTATION IN KIDNEY DEVELOPMENT AND WILMS TUMORIGENESIS" (2011). The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access). 203. https://digitalcommons.library.tmc.edu/utgsbs_dissertations/203 This Thesis (MS) is brought to you for free and open access by the The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences at DigitalCommons@TMC. It has been accepted for inclusion in The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences Dissertations and Theses (Open Access) by an authorized administrator of DigitalCommons@TMC. For more information, please contact [email protected]. DYSREGULATION OF MEOX2 FOLLOWING WT1 MUTATION IN KIDNEY DEVELOPMENT AND WILMS TUMORIGENESIS by LaGina Merie Nosavanh, B.S.
    [Show full text]
  • Wilms' Tumor Suppressor Gene WT1: from Structure to Renal
    J Am Soc Nephrol 11: S106–S115, 2000 Wilms’ Tumor Suppressor Gene WT1: From Structure to Renal Pathophysiologic Features CHRISTIAN MROWKA*† and ANDREAS SCHEDL* *Max Delbru¨ck Center for Molecular Medicine and †Franz Volhard Clinic, Humboldt University of Berlin, Berlin-Buch, Germany. Abstract. Normal development of the kidney is a highly com- current understanding of the structural features of WT1, how plex process that requires precise orchestration of proliferation, they modulate the transcriptional and post-transcriptional ac- differentiation, and apoptosis. In the past few years, a number tivities of the protein, and how mutations affecting individual of genes that regulate these processes, and hence play pivotal isoforms can lead to diseased kidneys is summarized. In addi- roles in kidney development, have been identified. The Wilms’ tion, results from transgenic experiments, which have yielded tumor suppressor gene WT1 has been shown to be one of these important findings regarding the function of WT1 in vivo, are essential regulators of kidney development, and mutations in discussed. Finally, data on the unusual feature of RNA editing this gene result in the formation of tumors and developmental of WT1 transcripts are presented, and the relevance of RNA abnormalities such as the Denys-Drash and Frasier syndromes. editing for the normal functioning of the WT1 protein in the A fascinating aspect of the WT1 gene is the multitude of kidney is discussed. isoforms produced from its genomic locus. In this review, our The kidney is crucial for survival. The molecular mechanisms Structural Features underlying the development of this organ, however, are only The human WT1 gene spans approximately 50 kb and in- beginning to be elucidated.
    [Show full text]
  • Original Article Associations of Novel Variants in PIK3C3, INSR and MAP3K4 of the ATM Pathway Genes with Pancreatic Cancer Risk
    Am J Cancer Res 2020;10(7):2128-2144 www.ajcr.us /ISSN:2156-6976/ajcr0116403 Original Article Associations of novel variants in PIK3C3, INSR and MAP3K4 of the ATM pathway genes with pancreatic cancer risk Ling-Ling Zhao1,2,3, Hong-Liang Liu2,3, Sheng Luo4, Kyle M Walsh2,5, Wei Li1, Qingyi Wei2,3,6 1Cancer Center, The First Hospital of Jilin University, Changchun, China; 2Duke Cancer Institute, Duke University Medical Center, Durham, NC, USA; Departments of 3Medicine, 4Biostatistics and Bioinformatics, 5Neurosurgery, 6Population Health Sciences, Duke University School of Medicine, Durham, NC, USA Received June 16, 2020; Accepted June 21, 2020; Epub July 1, 2020; Published July 15, 2020 Abstract: The ATM serine/threonine kinase (ATM) pathway plays important roles in pancreatic cancer (PanC) de- velopment and progression, but the roles of genetic variants of the genes in this pathway in the etiology of PanC are unknown. In the present study, we assessed associations between 31,499 single nucleotide polymorphisms (SNPs) in 198 ATM pathway-related genes and PanC risk using genotyping data from two previously published PanC genome-wide association studies (GWASs) of 15,423 subjects of European ancestry. In multivariable logis- tic regression analysis, we identified three novel independent SNPs to be significantly associated with PanC risk [PIK3C3 rs76692125 G>A: odds ratio (OR)=1.26, 95% confidence interval (CI)=1.12-1.43 and P=2.07×10-4, INSR rs11668724 G>A: OR=0.89, 95% CI=0.84-0.94 and P=4.21×10-5 and MAP3K4 rs13207108 C>T: OR=0.83, 95% CI=0.75-0.92, P=2.26×10-4].
    [Show full text]
  • Wt1 Directs the Lineage Specification of Sertoli and Granulosa Cells By
    © 2017. Published by The Company of Biologists Ltd | Development (2017) 144, 44-53 doi:10.1242/dev.144105 RESEARCH ARTICLE Wt1 directs the lineage specification of sertoli and granulosa cells by repressing Sf1 expression Min Chen1,*, Lianjun Zhang1,2,*, Xiuhong Cui1, Xiwen Lin1, Yaqiong Li1,2, Yaqing Wang3, Yanbo Wang1,2, Yan Qin1,2, Dahua Chen1, Chunsheng Han1, Bin Zhou4, Vicki Huff5 and Fei Gao1,‡ ABSTRACT Leydig cells and theca-interstitial cells are the steroidogenic cells Supporting cells (Sertoli and granulosa) and steroidogenic cells in male and female gonads, respectively. The steroid hormones (Leydig and theca-interstitium) are two major somatic cell types in produced by steroidogenic cells play essential roles in germ cell mammalian gonads, but the mechanisms that control their development and in maintaining secondary sexual characteristics. differentiation during gonad development remain elusive. In this Leydig cells first appear in testes at E12.5, whereas theca-interstitial study, we found that deletion of Wt1 in the ovary after sex cells are observed postnatally in the ovaries along with the determination caused ectopic development of steroidogenic cells at development of ovarian follicles. The origins of Leydig cells the embryonic stage. Furthermore, differentiation of both Sertoli and (Weaver et al., 2009; Barsoum and Yao, 2010; DeFalco et al., 2011) granulosa cells was blocked when Wt1 was deleted before sex and theca cells (Liu et al., 2015) have been studied previously. determination and most genital ridge somatic cells differentiated into However, the underlying mechanism that regulates the steroidogenic cells in both male and female gonads. Further studies differentiation between supporting cells and steroidogenic cells revealed that WT1 repressed Sf1 expression by directly binding to the during gonad development is poorly understood.
    [Show full text]
  • Activation of the Wt1 Wilms' Tumor Suppressor Gene by NF-Кb
    Oncogene (1998) 16, 2033 ± 2039 1998 Stockton Press All rights reserved 0950 ± 9232/98 $12.00 http://www.stockton-press.co.uk/onc Activation of the wt1 Wilms' tumor suppressor gene by NF-kB Mohammed Dehbi1, John Hiscott2 and Jerry Pelletier1,3 1Department of Biochemistry and 3Department of Oncology, McGill University, 3655 Drummond St., MontreÂal, QueÂbec, Canada, H3G 1Y6, and 2Lady Davis Institute for Medical Research, 3755 CoÃte Ste-Catherine, Montreal, QueÂbec, Canada, H3T 1E2 The Wilm's tumor suppressor gene, wt1, is expressed in the glutamine/proline rich amino (N-) terminus of a very de®ned spatial-temporal fashion and plays a key WT1, whereas the second alternatively spliced exon role in development of the urogenital system. Trans- results in the insertion of three amino acids, KTS, acting factors governing wt1 expression are poorly between the third and the fourth zinc ®ngers (for a de®ned. The presence of putative kB binding sites within review, see Reddy and Licht, 1996). WT1 has several the wt1 gene prompted us to investigate whether key structural features of a transcription factor such as members of the NF-kB/Rel family of transcription nuclear localization, a proline/glutamine N-terminal factors are involved in regulating wt1 expression. In rich region, and a DNA-binding domain consisting of transient transfection assays, ectopic expression of p50 four zinc ®ngers. Three of the four zinc ®ngers (II, III and p65 subunits of NF-kB stimulated wt1 promoter and IV) share extensive homology with those of the activity 10 ± 30-fold. Deletion mutagenesis revealed that early growth response (EGR) family of transcription NF-kB responsiveness is mediated by a short DNA factors and consequently, WT1 can bind to, and fragment located within promoter proximal sequences of regulate, the expression of numerous genes through the major transcription start site.
    [Show full text]